MedTrace Logo

Propensity to Hospitalize Patients From the ED in European Centers.

NCT06354764 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 162000

Last updated 2026-05-20

No results posted yet for this study

Summary

The peer-to-peer comparison means center-to-center comparison, which requires adjusting for possible differences among centers to be fair and convincing. The first step to reach this goal is to develop a predictive model that accurately estimates each patient's probability of being admitted, starting from clinical conditions and boundary variables. Such a model would make it possible to calculate, for each ED, the expected hospitalization rate; that is, the hospitalization rate that would have been observed if the ED had behaved like the average of the EDs that provided the data to build the model itself. Comparing the observed hospitalization rate in the single ED with the expected rate derived from the model provides a rigorous method of comparing the department with the average performance, taking into account the characteristics of the patients treated and the conditions under which the ED operated. In other words, the predictive model represents the benchmark against which each ED is evaluated.

Conditions

  • Emergency Medicine

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Astir s.r.l.

    collaborator INDUSTRY

  • Centre Hospitalier Universitaire Vaudois

    collaborator OTHER

  • Orobix Life S.r.l.

    collaborator UNKNOWN

  • Fondazione Bruno Kessler

    collaborator OTHER

  • Mario Negri Institute for Pharmacological Research

    lead OTHER

Principal Investigators

  • Guido Bertolini, MD · Istituto Di Ricerche Farmacologiche Mario Negri

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-22
Primary Completion
2026-06-30
Completion
2027-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06354764 on ClinicalTrials.gov